Dr. Behrens has received speaking fees (less than $10,000) from Sanofi-Aventis.
Leflunomide in psoriatic arthritis: Results from a large European prospective observational study
Version of Record online: 26 FEB 2013
Copyright © 2013 by the American College of Rheumatology
Arthritis Care & Research
Volume 65, Issue 3, pages 464–470, March 2013
How to Cite
Behrens, F., Finkenwirth, C., Pavelka, K., S̆tolfa, J., S̆ipek-Dolnicar, A., Thaçi, D. and Burkhardt, H. (2013), Leflunomide in psoriatic arthritis: Results from a large European prospective observational study. Arthritis Care Res, 65: 464–470. doi: 10.1002/acr.21848
- Issue online: 21 FEB 2013
- Version of Record online: 26 FEB 2013
- Accepted manuscript online: 6 OCT 2012 10:27AM EST
- Manuscript Accepted: 29 AUG 2012
- Manuscript Received: 20 FEB 2012
Additional Supporting Information may be found in the online version of this article.
|ACR_21848_sm_SupplTable1.doc||28K||Supplementary Table 1|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.